The Cetuximab Biosimilar Market is experiencing a significant transformation as healthcare systems and pharmaceutical companies prioritize cost-effective oncology treatments. As patent expirations of originator biologics approach, the entry of biosimilars is set to revolutionize patient access to life-saving cancer therapies. The growing prevalence of colorectal and head and neck cancers...